Insurer Anthem profit beats estimates on lower patient costs

Go back to Insurer Anthem profit beats estimates on lower patient costs

Centene (CNC) PT Raised to $146 at Oppenheimer Following 2Q

July 25, 2018 9:34 AM EDT

Oppenheimer raised its price target on Centene (NYSE: CNC) to $146.00 (from $138.00) while maintaining a Outperform rating following the company's 2Q earnings report. CNC reported 2Q adjusted EPS of $1.80, beating the Street estimates of $1.77. Adjusted results did benefit from ~$0.30 of risk-adjustment revenues that caused... More

Centene (CNC) PT Raised to $152 at Piper Jaffray

July 25, 2018 8:26 AM EDT

Piper Jaffray raised its price target on Centene (NYSE: CNC) to $152.00 (from $144.00) while maintaining a Overweight rating. Analyst Sarah James believes the company is a likely winner on two contracts in 2H18 which could drive 2019/2020 growth above estimates and... More